Sugammadex vs neostigmine in post-anesthesia recovery: A systematic review and meta-analysis
Open Access
- 2 August 2025
- journal article
- research article
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 26 (2) , 295-306
Abstract
Residual neuromuscular blockade (RNB) is linked to an increased risk of perioperative adverse events. This study systematically evaluates the impact of neuromuscular blockade antagonists on postoperative complications and quality of recovery in surgical patients. We conducted a systematic review and meta-analysis to compare the efficacy of sugammadex and neostigmine. Comprehensive searches were performed across medical databases, including Web of Science, PubMed, Embase, and the Cochrane Library, with a final search date of April 6, 2025. A total of thirty-five randomized controlled trials (RCTs) involving 4,275 patients, along with two retrospective studies comprising 49,642 participants, met the inclusion criteria. The meta-analysis revealed that sugammadex facilitated faster reversal of RNB compared to neostigmine, as indicated by a quicker recovery to a train-of-four ratio (TOFR) ≥ 0.9 (standardized mean difference [SMD] -3.45; 95% confidence interval [CI], -4.42 to -2.48), a shorter extubation time (SMD -1.44; 95% CI, -2.02 to -0.85), and a decreased incidence of RNB (risk ratio [RR] 0.18; 95% CI, 0.07 to 0.47). Moreover, sugammadex significantly reduced postoperative complications compared to neostigmine, including the incidence of postoperative nausea and vomiting (PONV) (RR 0.64; 95% CI, 0.46 to 0.88), postoperative pulmonary complications (PPCs) (RR 0.62; 95% CI, 0.38 to 0.99), and bradycardia (RR 0.32; 95% CI, 0.20 to 0.50). In conclusion, sugammadex provides a faster reversal of neuromuscular blockade compared to neostigmine and is associated with a reduction in postoperative complications. However, this expedited reversal does not result in measurable improvements in overall recovery quality, nor do either sugammadex or neostigmine significantly affect postoperative cognitive function.Keywords
This publication has 64 references indexed in Scilit:
- The Duration of Residual Neuromuscular Block After Administration of Neostigmine or Sugammadex at Two Visible Twitches During Train-of-Four MonitoringAnesthesia & Analgesia, 2011
- Residual Neuromuscular BlockAnesthesia & Analgesia, 2010
- An estimation of the global volume of surgery: a modelling strategy based on available dataThe Lancet, 2008
- Neostigmine but not sugammadex impairs upper airway dilator muscle activity and breathingBritish Journal of Anaesthesia, 2008
- Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmineBritish Journal of Anaesthesia, 2008
- Sugammadex Reversal of Rocuronium-Induced Neuromuscular Blockade: A Comparison with Neostigmine???Glycopyrrolate and Edrophonium???AtropineAnesthesia & Analgesia, 2007
- Effect of Neostigmine on Organ Injury in Murine Endotoxemia: Missing Facts about the Cholinergic Antiinflammatory PathwayWorld Journal of Surgery, 2005
- Accelerometry of Adductor Pollicis Muscle Predicts Recovery of Neuromuscular Blockade in Anesthetized PatientsAnesthesiology, 2003
- Functional Assessment of the Pharynx at Rest and during Swallowing in Partially Paralyzed HumansAnesthesiology, 1997
- Residual neuromuscular block is a risk factor for postoperative pulmonary complications A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuroniumActa Anaesthesiologica Scandinavica, 1997